Development of diffuse large B-cell lymphoma after sofosbuvir-ledipasvir treatment for chronic hepatitis C: A case report and literature review

Recently, treatments for chronic hepatitis C virus (HCV) infection have significantly improved by the development of direct-acting antiviral agents (DAAs) and almost all patients with HCV can complete antiviral treatment without apparent adverse events. Malignant lymphoma, particularly B-cell non-Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Hiroyasu, Miwa, Takao, Ikoma, Yoshikazu, Hanai, Tatsunori, Nakamura, Nobuhiko, Imai, Kenji, Kitagawa, Junichi, Shirakami, Yohei, Kanemura, Nobuhiro, Suetsugu, Atsushi, Takai, Koji, Shiraki, Makoto, Shimizu, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391802/
https://www.ncbi.nlm.nih.gov/pubmed/32754315
http://dx.doi.org/10.3892/mco.2020.2071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391802/
https://www.ncbi.nlm.nih.gov/pubmed/32754315
http://dx.doi.org/10.3892/mco.2020.2071

Ejemplares similares